Sutro Biopharma (STRO) Shares Issued (2018 - 2025)

Sutro Biopharma has disclosed Shares Issued across 8 years of filings, most recently posting $4000.0 for Q4 2025.

• Shares Issued for Q4 2025 came in at $4000.0, up 100.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $4000.0 (up 100.01% YoY), and the FY2025 annual result was $4000.0, down 98.52% from the prior year.
• Shares Issued came in at $4000.0 for Q4 2025 at Sutro Biopharma, up from -$246000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $10.9 million in Q3 2023 to a low of -$50.0 million in Q2 2024.
• The 5-year median for Shares Issued is $246000.0 (2025), against an average of -$3.8 million.
• Peak annual rise in Shares Issued reached 1761.73% in 2022, while the deepest fall reached 4463.75% in 2022.
• Sutro Biopharma's Shares Issued stood at $513000.0 in 2021, then plunged by 1461.01% to -$7.0 million in 2022, then jumped by 255.74% to $10.9 million in 2023, then sank by 327.41% to -$24.7 million in 2024, then soared by 100.02% to $4000.0 in 2025.
• The last three Shares Issued figures came in at $4000.0 (Q4 2025), -$246000.0 (Q2 2025), and $246000.0 (Q1 2025), per Business Quant data.